Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
OXYGEN, USP is a pharmaceutical-grade oxygen gas administered via inhalation to patients requiring supplemental oxygen therapy. It is an essential therapeutic gas used across acute and chronic respiratory conditions. The product works by increasing oxygen saturation in the bloodstream to support cellular respiration and tissue oxygenation.
As a mature, essential therapeutic product in peak lifecycle, roles are stable but limited to maintenance and operational optimization rather than aggressive growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Endoscopic COlorectal Mucosal Evaluation of Oxygen Tension
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Normobaric Oxygen Therapy in Colorectal Cancer Patients
Worked on OXYGEN, USP at Universal Cells? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on OXYGEN, USP offers stability in a mature, essential product but limited upside for career growth or high-visibility innovation projects. Professionals on this team develop deep expertise in supply chain, regulatory compliance, and healthcare infrastructure—valuable skills but with less dynamic commercial opportunity than growth-stage products.